4Dougherty T J. Photosensitizers: therapy and detection of malignant tumors [ J ]. Photochem Photobiol, 1987,45 (6) : 879 - 889.
5Loh C S, MacRobert A J, Bedwell J, et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy[J]. Br J Cancer, 1993, 68(1) : 41 -51.
6Choudry K, Brooke R C, Farrar W, et al. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5- aminolaevulinic acid photodynamic therapy[ J]. Br J Dermatol, 2003, 149(1) : 124 -130.
9Varms S, Wilson H, Kurwa H A, et al. Bowen' s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamie therapy using a large-field incoherent light source[ J]. Br J Dermatol, 2001, 144(3) : 567 -574.
6Dahle J, Steen HB, Moan J. The mode of cell death induced by photodynamic treatment depends on cell density [J]. Photochem Photobiol, 1999, 70(3): 363-367.
7Frank RG, Bos JD. Photodynamic therapy for condylomata acuminata with local application of 5-aminolivulinic acid [J]. Genitourinary Med, 1996, 72(1): 70-71.
8Wolf P, Rieger E, Kerl H., Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas and basal cell carcinomas? J Am Acad Dermatol, 1993, 1, 17.
9Morton CA, Whitehurst C, Moseley H et al, Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease, Br J Dermatol,1996,5,766.
10Hillemanns P, Untch M, Dannecker C et al., Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer, 2000, 5, 649.
